Annual EBIT
-$64.65 M
+$29.47 M+31.31%
31 December 2023
Summary:
Assembly Biosciences annual earnings before interest & taxes is currently -$64.65 million, with the most recent change of +$29.47 million (+31.31%) on 31 December 2023. During the last 3 years, it has risen by +$130.00 thousand (+0.20%). ASMB annual EBIT is now -1835.39% below its all-time high of -$3.33 million.ASMB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$10.96 M
+$1.25 M+10.22%
30 September 2024
Summary:
Assembly Biosciences quarterly earnings before interest & taxes is currently -$10.96 million, with the most recent change of +$1.25 million (+10.22%) on 30 September 2024. Over the past year, it has increased by +$4.09 million (+27.19%). ASMB quarterly EBIT is now -266.53% below its all-time high of $6.58 million, reached on 30 June 2020.ASMB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$46.44 M
+$4.09 M+8.10%
30 September 2024
Summary:
Assembly Biosciences TTM earnings before interest & taxes is currently -$46.44 million, with the most recent change of +$4.09 million (+8.10%) on 30 September 2024. Over the past year, it has increased by +$28.63 million (+38.14%). ASMB TTM EBIT is now -3832.51% below its all-time high of -$1.18 million, reached on 31 March 2009.ASMB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.3% | +27.2% | +38.1% |
| 3 y3 years | +0.2% | +42.0% | +57.6% |
| 5 y5 years | +30.3% | +57.9% | +53.7% |
ASMB EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +31.3% | -2.1% | +55.4% | at high | +57.6% |
| 5 y | 5 years | at high | +37.1% | -266.5% | +72.4% | at high | +57.6% |
| alltime | all time | -1835.4% | +37.1% | -266.5% | +72.4% | -3832.5% | +57.6% |
Assembly Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.96 M(-10.2%) | -$46.44 M(-8.1%) |
| June 2024 | - | -$12.20 M(+13.7%) | -$50.53 M(-9.5%) |
| Mar 2024 | - | -$10.73 M(-14.5%) | -$55.82 M(-13.7%) |
| Dec 2023 | -$64.65 M(-31.3%) | -$12.55 M(-16.6%) | -$64.65 M(-13.9%) |
| Sept 2023 | - | -$15.05 M(-14.0%) | -$75.07 M(-10.0%) |
| June 2023 | - | -$17.49 M(-10.6%) | -$83.43 M(-7.8%) |
| Mar 2023 | - | -$19.56 M(-14.9%) | -$90.51 M(-3.8%) |
| Dec 2022 | -$94.11 M(+3.4%) | -$22.98 M(-1.8%) | -$94.11 M(+1.9%) |
| Sept 2022 | - | -$23.40 M(-4.8%) | -$92.39 M(+5.2%) |
| June 2022 | - | -$24.57 M(+6.1%) | -$87.86 M(+1.0%) |
| Mar 2022 | - | -$23.16 M(+9.0%) | -$86.95 M(-4.5%) |
| Dec 2021 | -$91.05 M(+40.6%) | -$21.25 M(+12.6%) | -$91.05 M(-16.8%) |
| Sept 2021 | - | -$18.88 M(-20.2%) | -$109.44 M(+15.7%) |
| June 2021 | - | -$23.67 M(-13.2%) | -$94.58 M(+47.0%) |
| Mar 2021 | - | -$27.26 M(-31.2%) | -$64.34 M(-0.7%) |
| Dec 2020 | -$64.78 M(-36.9%) | -$39.64 M(+886.4%) | -$64.78 M(+20.4%) |
| Sept 2020 | - | -$4.02 M(-161.1%) | -$53.82 M(-29.0%) |
| June 2020 | - | $6.58 M(-123.8%) | -$75.79 M(-25.7%) |
| Mar 2020 | - | -$27.69 M(-3.5%) | -$102.07 M(-0.6%) |
| Dec 2019 | -$102.71 M(+10.8%) | -$28.68 M(+10.4%) | -$102.71 M(+2.4%) |
| Sept 2019 | - | -$25.99 M(+31.9%) | -$100.35 M(+3.5%) |
| June 2019 | - | -$19.70 M(-30.5%) | -$96.93 M(-7.2%) |
| Mar 2019 | - | -$28.34 M(+7.7%) | -$104.40 M(+12.6%) |
| Dec 2018 | -$92.73 M(+77.6%) | -$26.32 M(+16.6%) | -$92.73 M(+17.8%) |
| Sept 2018 | - | -$22.57 M(-16.9%) | -$78.69 M(+14.8%) |
| June 2018 | - | -$27.17 M(+62.9%) | -$68.57 M(+24.7%) |
| Mar 2018 | - | -$16.67 M(+35.8%) | -$54.97 M(+5.3%) |
| Dec 2017 | -$52.23 M(+15.3%) | -$12.28 M(-1.4%) | -$52.23 M(+0.8%) |
| Sept 2017 | - | -$12.45 M(-8.2%) | -$51.82 M(+1.5%) |
| June 2017 | - | -$13.57 M(-2.6%) | -$51.04 M(+6.5%) |
| Mar 2017 | - | -$13.93 M(+17.4%) | -$47.93 M(+5.9%) |
| Dec 2016 | -$45.28 M | -$11.87 M(+1.6%) | -$45.28 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | -$11.68 M(+11.7%) | -$41.59 M(+12.3%) |
| June 2016 | - | -$10.45 M(-7.3%) | -$37.03 M(+9.8%) |
| Mar 2016 | - | -$11.28 M(+37.9%) | -$33.73 M(+13.7%) |
| Dec 2015 | -$29.66 M(+23.8%) | -$8.18 M(+14.8%) | -$29.66 M(+6.8%) |
| Sept 2015 | - | -$7.12 M(-0.4%) | -$27.76 M(-12.4%) |
| June 2015 | - | -$7.15 M(-0.7%) | -$31.70 M(+17.2%) |
| Mar 2015 | - | -$7.20 M(+14.6%) | -$27.05 M(+12.9%) |
| Dec 2014 | -$23.96 M(+22.2%) | -$6.28 M(-43.2%) | -$23.96 M(+0.8%) |
| Sept 2014 | - | -$11.06 M(+341.1%) | -$23.77 M(+34.7%) |
| June 2014 | - | -$2.51 M(-39.0%) | -$17.64 M(-11.5%) |
| Mar 2014 | - | -$4.11 M(-32.6%) | -$19.95 M(+2.0%) |
| Dec 2013 | -$19.60 M(-20.9%) | -$6.09 M(+23.5%) | -$19.56 M(+13.3%) |
| Sept 2013 | - | -$4.93 M(+2.6%) | -$17.26 M(-2.4%) |
| June 2013 | - | -$4.81 M(+29.2%) | -$17.68 M(-13.1%) |
| Mar 2013 | - | -$3.72 M(-1.8%) | -$20.34 M(-18.0%) |
| Dec 2012 | -$24.79 M(-26.9%) | -$3.79 M(-29.2%) | -$24.79 M(-37.7%) |
| Sept 2012 | - | -$5.36 M(-28.3%) | -$39.81 M(-0.5%) |
| June 2012 | - | -$7.47 M(-8.6%) | -$40.00 M(+1.4%) |
| Mar 2012 | - | -$8.17 M(-56.5%) | -$39.45 M(+16.2%) |
| Dec 2011 | -$33.93 M(+612.6%) | -$18.81 M(+239.2%) | -$33.96 M(+85.7%) |
| Sept 2011 | - | -$5.55 M(-19.9%) | -$18.28 M(+38.0%) |
| June 2011 | - | -$6.92 M(+158.4%) | -$13.25 M(+70.5%) |
| Mar 2011 | - | -$2.68 M(-14.7%) | -$7.77 M(+43.6%) |
| Dec 2010 | -$4.76 M(+42.5%) | -$3.14 M(+515.3%) | -$5.41 M(+62.7%) |
| Sept 2010 | - | -$510.30 K(-64.6%) | -$3.33 M(-5.8%) |
| June 2010 | - | -$1.44 M(+354.6%) | -$3.53 M(+42.5%) |
| Mar 2010 | - | -$317.50 K(-69.9%) | -$2.48 M(-25.8%) |
| Dec 2009 | -$3.34 M(-53.4%) | -$1.05 M(+47.7%) | -$3.34 M(+46.2%) |
| Sept 2009 | - | -$714.30 K(+83.2%) | -$2.29 M(+45.5%) |
| June 2009 | - | -$390.00 K(-67.0%) | -$1.57 M(+33.0%) |
| Mar 2009 | - | -$1.18 M | -$1.18 M |
| Dec 2008 | -$7.16 M | - | - |
FAQ
- What is Assembly Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Assembly Biosciences?
- What is Assembly Biosciences annual EBIT year-on-year change?
- What is Assembly Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Assembly Biosciences?
- What is Assembly Biosciences quarterly EBIT year-on-year change?
- What is Assembly Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Assembly Biosciences?
- What is Assembly Biosciences TTM EBIT year-on-year change?
What is Assembly Biosciences annual earnings before interest & taxes?
The current annual EBIT of ASMB is -$64.65 M
What is the all time high annual EBIT for Assembly Biosciences?
Assembly Biosciences all-time high annual earnings before interest & taxes is -$3.33 M
What is Assembly Biosciences annual EBIT year-on-year change?
Over the past year, ASMB annual earnings before interest & taxes has changed by +$29.47 M (+31.31%)
What is Assembly Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of ASMB is -$10.96 M
What is the all time high quarterly EBIT for Assembly Biosciences?
Assembly Biosciences all-time high quarterly earnings before interest & taxes is $6.58 M
What is Assembly Biosciences quarterly EBIT year-on-year change?
Over the past year, ASMB quarterly earnings before interest & taxes has changed by +$4.09 M (+27.19%)
What is Assembly Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of ASMB is -$46.44 M
What is the all time high TTM EBIT for Assembly Biosciences?
Assembly Biosciences all-time high TTM earnings before interest & taxes is -$1.18 M
What is Assembly Biosciences TTM EBIT year-on-year change?
Over the past year, ASMB TTM earnings before interest & taxes has changed by +$28.63 M (+38.14%)